Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)
The purpose of this Funding Opportunity Announcement (FOA) is to complete treatment of the participants recruited into the Preventing Early Renal Loss in Diabetes (PERL) Study and to analyze the outcomes of the trial.
PERL is a randomized, double-blind trial to test whether the medication, allopurinol,
can slow the progression of kidney disease in people with type 1 diabetes and early diabetic kidney disease.
PERL is a randomized, double-blind trial to test whether the medication, allopurinol,
can slow the progression of kidney disease in people with type 1 diabetes and early diabetic kidney disease.
Related Programs
Diabetes, Digestive, and Kidney Diseases Extramural Research
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $7,000,000
Office: National Institutes of Health
Estimated Funding: $7,000,000
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-16-506.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
This FOA is a limited competition for the continuation of the PERL study, which was previously funded under RFA-DK-12-511.
Only the currently funded Clinical Research Center (CRC) is eligible to apply.
Only the currently funded Biostatistics Research Center (BRC) and clinical sites are eligible to be subcontracts to the CRC.
see FOA for Eligibility Details
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-16-506.html
Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2016-12-01
Application Due Date:
2017-03-02
Archive Date:
2017-04-02
Social Entrepreneurship
Spotlight
Calgary Social Enterprise Offers High-Tech Services by People with Autism
Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.
Learn How to Identify and Avoid Grant Scams
